DEF 14A: CARGO Therapeutics Sets Date for 2024 Annual Stockholders Meeting

CARGO Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 4, 2024, to vote on the election of directors and ratification of the independent auditor.

Summary

• CARGO Therapeutics, Inc. will hold its 2024 Annual Meeting of Stockholders on June 4, 2024, at 9:00 a.m. Pacific Time in a virtual format.
• Stockholders of record as of April 5, 2024, are eligible to vote.
• The meeting will address the election of two Class I directors, the ratification of Deloitte & Touche LLP as the independent auditor for the year ending December 31, 2024, and any other business that may properly come before the meeting.
• The Board of Directors recommends voting FOR the election of the director nominees and FOR the ratification of the independent auditor appointment.
• The company's common stock outstanding as of the record date was 39,368,647 shares.
• Stockholders can vote online during the meeting or submit their proxy via the internet, phone, or mail before the meeting.

Sentiment

Score: 7

Explanation: The document is factual and procedural, with a neutral to slightly positive tone due to the CEO's expression of gratitude and invitation to the meeting.

Positives

• The company is adhering to good corporate governance practices by seeking stockholder ratification of the independent auditor.
• The board is recommending qualified candidates for election as directors.
• The company provides multiple convenient methods for stockholders to vote.

Future Outlook

The document outlines the business to be conducted at the Annual Meeting and encourages stockholders to vote.

Management Comments

• Gina Chapman, Chief Executive Officer, thanks stockholders for their support and invites them to attend the 2024 Annual Meeting.

Industry Context

This is a standard proxy statement related to the annual meeting of stockholders, a routine event for publicly traded companies.

Comparison to Industry Standards

• The structure and content of this proxy statement are consistent with industry standards for publicly traded companies in the United States.
• The proposals to elect directors and ratify the auditor are typical agenda items for annual meetings.
• The disclosure of related party transactions and executive compensation aligns with SEC regulations and best practices.

Stakeholder Impact

• Shareholders are asked to vote on key governance matters.
• The outcome of the votes will influence the composition of the Board and the selection of the company's auditor.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting on June 4, 2024.
• The company will announce the voting results via a Current Report on Form 8-K within four business days after the Annual Meeting.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Director Election, Auditor Ratification, Corporate Governance, CARGO Therapeutics